Serum lipids and smoking status in coronary heart disease patients treated with simvastatin

QR Code

Serum lipids and smoking status in coronary heart disease patients treated with simvastatin

Aim. To study the effectiveness of generic simvastatin in hyperlipidaemia (HLP) correction (isolated hypercholesterolemia, HCH, or HCH combined with hypertriglyceridemia, HTG) in patients with confirmed diagnosis of coronary heart disease (CHD), in regard to their smoking status. Material and method...

Full description

Saved in:

Bibliographic Details
Main Authors:	L. R. Gazdanova, V. A. Metelskaya, I. E. Koltunov, N. M. Akhmedzhanov, E. B. Yarovaya
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2010-04-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	lipids lipoproteins cholesterol hyperlipidaemia smoking generic statins
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/2036
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PCSK9 Inhibitor Therapy as an Alternative for Statin Intolerance
by: K. O. Shnaider, et al.
Published: (2023-12-01)

COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS
by: S. N. Tolpygina, et al.
Published: (2016-01-01)

EFFECT OF SIMVASTATIN ON MARKERS OF CARDIOVASCULAR RISK
by: N. V. Perova, et al.
Published: (2016-01-01)

Familial hypercholesterolemia: current status of the problem, treatment, and prevention
by: S. A. Bliznyuk, et al.
Published: (2020-11-01)

Lipid-lowering therapy: modern possibilities and real clinical practice
by: A. V. Blokhina, et al.
Published: (2022-09-01)

Atorvastatin and simvastatin in clinical management of high-risk patients
by: S. A. Shalnova, et al.
Published: (2009-02-01)

New perspectives in treating high-risk cardiac patients. Rosuvastain and it’s perspectives for clinical practice use
by: M. G. Bubnova
Published: (2007-12-01)

A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC SIMVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA
by: V. P. Voronina, et al.
Published: (2016-01-01)

PROATHEROGENIC LIPID AND LIPOPROTEIN METABOLIC DISTURBANCES IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: E. V. Gerasimova, et al.
Published: (2017-07-01)

Bempedoic Acid: Safety and Efficiacy of a New Lipid-Lowering Agent
by: I. A. Mazerkina, et al.
Published: (2023-09-01)

Contradictions in traditional ideas about atherosclerosis and the efficacy of lipid-lowering therapy. Promising directions
by: A. P. Vasiliev, et al.
Published: (2024-08-01)

ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT?
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

Dyslipidemia in the Russian Federation: population data, associations with risk factors
by: O. M. Drapkina, et al.
Published: (2023-12-01)

Review and analysis of 2023 Clinical Guidelines for Lipid Metabolism Disorders
by: I. V. Sergienko, et al.
Published: (2023-12-01)

Linking Lipid Profile to Stress Urinary Incontinence in US Women: A National Cross-Sectional Study
by: Lu M, et al.
Published: (2025-06-01)

Assessment of lipid profile when using lipid-lowering therapy (statins) in patients with coronary atherosclerosis
by: N. E. Gavrilova, et al.
Published: (2015-11-01)

Simultaneous inhibition of cholesterol absorption and synthesis in combined therapy with ezetimibe and simvastatin
by: D. M. Aronov
Published: (2005-08-01)

Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation
by: E. V. Udachkina, et al.
Published: (2015-11-01)

Disorders of lipid metabolism. Clinical Guidelines 2023
by: M. V. Ezhov, et al.
Published: (2023-06-01)

Statin therapy and atherosclerosis regression
by: A. V. Susekov
Published: (1970-01-01)

Double cholesterol inhibition — a new approach to effective control of hyperlipidemia and atherosclerosis
by: A. V. Susekov, et al.
Published: (2009-12-01)

THE EFFECT OF SMOKING ON THE COURSE OF THE DISEASE AND LIPID METABOLISM IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA
by: Olena Sorokopud, et al.
Published: (2025-06-01)

Serum albumin combined with high-density lipoprotein cholesterol as a novel marker to predict coronary heart disease: are their associations multiplicative or rateable?
by: Li He, et al.
Published: (2025-07-01)

Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and Sarcopenic obesity in U.S. adults: a cross-sectional study
by: Jiao Liu, et al.
Published: (2025-08-01)

THE EFFECT OF ROSELLA DRIED CALYX INFUSION (HIBISCUS SABDARIFFA) IN LOWERING LDL CHOLESTEROL SERUM LEVEL ON CIGARETTE SMOKE EXPOSED MALE SPRAGUE DAWLEY RATS
by: Gabriela Rolanda, et al.
Published: (2022-01-01)

Eurasian Association of Cardiology (EAC)/ Russian National Atherosclerosis Society (RNAS) Guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis (2025)
by: M. V. Ezhov, et al.
Published: (2025-06-01)

Addressing Dyslipidaemia in Advanced CKD: Insights from a Secondary Care Cohort
by: Tom Siby, et al.
Published: (2025-05-01)

Conundrum of Cholesterol Management and Health Implications of Low Cholesterol Levels: A Narrative Review
by: Subodh Bashyal, et al.
Published: (2025-07-01)

EFFICACY OF ROSUVASTATIN IN DYSLIPIDEMIA CORRECTION IN PATIENTS AFTER Q-WAVE MYOCARDIAL INFARCTION
by: R. D. Kurbanov, et al.
Published: (2015-09-01)

RATIONAL APPROACHES TO THE TREATMENT OF DYSLIPIDEMIA WITH DIFFERENT TOTAL CARDIOVASCULAR RISK AND ACUTE CORONARY SYNDROME
by: N. V. Perova, et al.
Published: (2015-09-01)

Effect of aqueous extract of olive (Olea europaea) fruit on lipid profile in female rabbits
by: Baghdad Science Journal
Published: (2010-12-01)

Lipid profile in hospitalized patients with COVID-19 depending on the outcome of its acute phase: data from the international registry "Dynamics analysis of comorbidities in SARS-CoV-2 infection survivors"
by: G. P. Arutyunov, et al.
Published: (2022-09-01)

THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015
by: S. A. Smetnev, et al.
Published: (2017-01-01)

Comparison of the effect of the alcoholic extract of leaves and fruits of hawthorn plant Crataegus azarolus with the drug simvastatin in its effect in reducing cardiovascular disease in male rabbits with experimental fat disorder
by: Muhanned H. Mukhlif Al-Obaidy, et al.
Published: (2018-08-01)

PROBLEM OF TREATMENT WITH STATINS IN RUSSIA: WILL GENERICS HELP?
by: S. Y. Martsevich
Published: (2016-01-01)

ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I
by: N. M. Akhmedzhanov, et al.
Published: (2015-09-01)

Fentanyl-induced transformations in composition of lipid droplets in central nervous system cells revealed by ramanomics
by: Rahul K. Das, et al.
Published: (2025-07-01)

Pathogenetic rationale for using an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and an antioxidant coenzyme Q<sub>10</sub> in the treatment and prevention of cardiovascular disease
by: S. G. Dzugkoev, et al.
Published: (2021-10-01)

Effect of simvastatin on fatty acids composition of erythrocyte membranes in women with chronic form of coronary heart disease
by: A. M. Dygai, et al.
Published: (2013-09-01)

Pharmacodynamics and clinical effectiveness of clopidogrel and atorvastin in patients with acute coronary syndrome and hyperlipidaemia
by: A. S. Sivkov, et al.
Published: (2009-08-01)